Vertical Aerospace Ltd. — Form 6-K Summary
Reporting context: The company furnished this Form 6-K for October 2026. It reports an NYSE continued-listing deficiency notice received on September 9, 2026.
Financial and operating metrics
This filing provides no revenue, profit, cash flow, margin, debt, or liquidity figures.
Material development
The NYSE notified Vertical Aerospace that its ordinary shares were out of compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price was below $1.00 per share for 30 consecutive trading days.
The company has six months from receipt of the notice to cure the deficiency. To regain compliance, on the last trading day of a calendar month within that period, the shares must have both a closing price of at least $1.00 and a 30-trading-day average closing price of at least $1.00. The company says it intends to cure the deficiency and remain listed. Its shares remain listed during the cure period, and the company does not anticipate an impact on ongoing operations.
Outlook, risks, and other disclosures
The company says it will consider available options to regain compliance. Its statements about regaining compliance, continued NYSE trading, share value, and operational impact are forward-looking and subject to risks, including those described in its Form 20-F filed March 24, 2026. The company disclaims an obligation to update forward-looking statements except as required by law.
Information in the 6-K, excluding Exhibit 99.1, is incorporated by reference into the company’s listed Form F-3 registration statements.
Investor verification points
- Track the share closing price and 30-trading-day average against the NYSE’s monthly cure test, and confirm the cure-period deadline.
- Verify whether the company regains compliance or receives further NYSE notices.
- Review Exhibit 99.1, the October 2, 2026 press release, and subsequent SEC filings for updates.